New nasal spray shows promise in treating sleep apnoea

Sleep apnoea, commonly associated with snoring, is a serious health condition where the throat tissue collapses and blocks the airway for about ten seconds during sleep. This disruption not only causes disturbed sleep but can also lead to more severe health problems, including heart disease, if left untreated.

Traditionally, managing sleep apnoea has been challenging and often requires invasive methods or continuous positive airway pressure (CPAP) therapy. However, a groundbreaking new method has emerged: a nasal spray developed by scientists that targets this condition.

This innovative nasal spray contains leptin, a hormone known for its role in regulating various bodily functions, including breathing. By incorporating leptin, the spray aims to help stabilize the airway and reduce the frequency of apnoea events during sleep.

The development of this nasal spray could provide significant relief for individuals who struggle with chronic snoring and sleep apnoea, offering a less intrusive treatment option compared to traditional methods.

As researchers continue to explore the efficacy of this nasal spray, it represents a promising advancement in the fight against sleep apnoea and its potential complications.

Key Points:

• Scientists have developed a new nasal spray to combat chronic sleep apnoea.
• The spray contains leptin, a hormone that regulates breathing.
• Untreated sleep apnoea can lead to serious health issues, including heart disease.